ADRIANO AUGUSTO MEIRELLES TRUFFA
Índice h a partir de 2011
1
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina - Médico
3 resultados
Resultados de Busca
Agora exibindo 1 - 3 de 3
bookPart Bradiarritmias(2016) MADRINI, Vagner; TRUFFA, Adriano A. M.; GUIMARãES, Hélio Penna- Left Main Compression by a Giant Aneurysm of the Left Sinus of Valsalva: An Extremely Rare Reason for Myocardial Infarction and Cardiogenic Shock(2015) FAILLACE, Bruno L. R.; GALON, Micheli Z.; OLIVEIRA, Marcos Danillo P.; PRADO JR., Guy F. A.; TRUFFA, Adriano A. M.; RIBEIRO, Expedito E.; LEMOS, Pedro A.Aneurysms of the sinus of Valsalva are very rare and mostly located in the right coronary sinus. They might course with dyspnea, fatigue, and acute coronary syndromes. We present herein an extremely rare case report of a 61-year-old woman diagnosed with external left main coronary compression by a giant aneurysm of the left sinus of Valsalva, which was successfully managed with percutaneous coronary intervention.
- Potential of transcatheter aortic valve replacement to improve post-procedure renal function(2017) FAILLACE, Bruno L. R.; RIBEIRO, Henrique B.; CAMPOS, Carlos M.; TRUFFA, Adriano A. M.; BERNARDI, Fernando L.; OLIVEIRA, Marcos D. P.; MARIANI JR., Jose; MARCHINI, Julio F.; TARASOUTCHI, Flavio; LEMOS, Pedro A.Background: Baseline comorbidities including renal dysfunction are frequently found in patients treated with transcatheter aortic valve replacement (TAVR) and may increase the risks of acute kidney injury (AKI), although some of them may actually improve renal function. We aimed to evaluate the potential of TAVR to acutely improve post-procedure renal function. Methods: This is a prospective single-center registry of consecutive patients with severe symptomatic aortic stenosis treated by transfemoral TAVR. Creatinine levels were determined at baseline and daily until hospital discharge. AKI was defined according to VARC-2 criteria. Patients who had improvement of creatinine levels >25% were classified as having TAVR induced renal function improvement (TIRFI). Results: A total of 69 patients undergoing TAVR were included, with a mean age of 83.0 +/- 7.4 years, being 24.6% diabetics, with a median STS score of 9.2 (5.1-21.6). Using the VARC-2 criteria, the majority of patients (64.6%) did not have renal impairment, while AKI was detected in 35.4% of the patients. Importantly, in those with prior severe renal dysfunction (clearance <30 mL/min/1.73 m(2)) or diabetes, AKI reached up to 50% and 56.3% of the patients, respectively. Conversely, acute kidney recovery (TIRFI) occurred in 12 patients (18.5%) being >50% in 1 patient (1.5%), and at hospital discharge the majority of the patients (88.6%) left the hospital in their original or better renal function categories. Conclusion: Despite multiple comorbidities in a selected TAVR-population and the use of contrast media, TAVR did not impair renal function in a majority of patients, with a significant proportion of them rather having acute renal function improvement.